Sublingual Estradiol Versus Oral Estradiol in 
Transgender Women  
[STUDY_ID_REMOVED]  
Protocol last modified 3/14/2021  
Sublingual Estradiol Versus Oral Estradiol in Transgender Women  
Protocol Summary  
Primary aim. To establish the pharmacokinetics of sublingual estradiol versus oral 
estradiol.  
Secondary aim. To compare estradiol by [CONTACT_29864] -MS/MS to estradiol by [CONTACT_45004].  
Design: To illuminate the pharmacokinetic parameters of sublingual estradiol in transgender 
women, a pi[INVESTIGATOR_403584]. Ten participants, transgender male -to-female 
patients who are naïve to hormone therapy, will be recruited from the Medical College of 
Wisconsin’s Inclusion Health Clinic.  
Methods: Each participant will be dosed with [ADDRESS_509018] one 
week will allow for complete clearance of the exogenous oral estradiol before testing the 
pharmacokinetics of sublingual estradiol 1 mg on the same t en patients in the same manner. 
Estradiol and estrone by [CONTACT_29864] -MS/MS will be measured , as well as estradiol by [CONTACT_45004] . 
These will be sent to ARUP.  
 